ONCOGENES AND TUMOR-GROWTH FACTORS IN BREAST-CANCER - A MINIREVIEW

被引:16
作者
ERNBERG, IT
机构
[1] Department of Tumor Biology, Karolinska Institute, Stockholm
关键词
Breast cancer; C-myc; Int-1; Neu; Oncogenes; Ras; RB-gene; Transgenic mice;
D O I
10.3109/02841869009090009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Five oncogenes have been implied as having a role in human breast tumorigenesis: int-2, c-erbB-2 (HER-2), c-myc, c-Ha-ras and the recessive Rb-1. As far as the function and biochemistry of these oncogenes have been studied, they act at different levels and have totally different functions in the cells. They are normally cellular genes, likely to have important functions in normal cell growth or differentiation. In the tumors their regulation or function is altered, due to a wide class of mutations. The oncogenes may cooperate to result in the malignant cell phenotype. However, different oncogenes are mutated in different tumors, so that the tumors show a variable pattern at the molecular level, underlining the individuality of these tumors already described as differences in histopathology, hormone receptor expression and clinical course. The main importance of the oncogene studies is still to reveal basic pathogenetic mechanisms. Where appropriate it is important to test diagnostic or prognostic significane of the oncogene mutations. ©1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:331 / 334
页数:4
相关论文
共 24 条
[1]  
ALI IU, 1989, ONCOGENE, V4, P89
[2]   HA-RAS ONCOGENE EXPRESSION DIRECTED BY A MILK PROTEIN GENE PROMOTER - TISSUE-SPECIFICITY, HORMONAL-REGULATION, AND TUMOR-INDUCTION IN TRANSGENIC MICE [J].
ANDRES, AC ;
SCHONENBERGER, CA ;
GRONER, B ;
HENNIGHAUSEN, L ;
LEMEUR, M ;
GERLINGER, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (05) :1299-1303
[3]  
BORG A, 1989, LANCET, V1, P1268
[4]   SPECIFIC ACTIVATION OF THE CELLULAR HARVEY-RAS ONCOGENE IN DIMETHYLBENZANTHRACENE-INDUCED MOUSE MAMMARY-TUMORS [J].
DANDEKAR, S ;
SUKUMAR, S ;
ZARBL, H ;
YOUNG, LJT ;
CARDIFF, RD .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (11) :4104-4108
[5]   GENETIC ALTERATION OF THE C-MYC PROTOONCOGENE (MYC) IN HUMAN PRIMARY BREAST CARCINOMAS [J].
ESCOT, C ;
THEILLET, C ;
LIDEREAU, R ;
SPYRATOS, F ;
CHAMPEME, MH ;
GEST, J ;
CALLAHAN, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (13) :4834-4838
[6]  
GRAHAM KA, 1985, CANCER RES, V45, P2201
[7]   SUPPRESSION OF THE NEOPLASTIC PHENOTYPE BY REPLACEMENT OF THE RB GENE IN HUMAN CANCER-CELLS [J].
HUANG, HJS ;
YEE, JK ;
SHEW, JY ;
CHEN, PL ;
BOOKSTEIN, R ;
FRIEDMANN, T ;
LEE, EYHP ;
LEE, WH .
SCIENCE, 1988, 242 (4885) :1563-1566
[8]  
LAVIALLE C, 1988, ONCOGENE, V3, P335
[9]   INACTIVATION OF THE RETINOBLASTOMA SUSCEPTIBILITY GENE IN HUMAN-BREAST CANCERS [J].
LEE, EYHP ;
TO, H ;
SHEW, JY ;
BOOKSTEIN, R ;
SCULLY, P ;
LEE, WH .
SCIENCE, 1988, 241 (4862) :218-221
[10]   A CHIMERIC EGF-R-NEU PROTO-ONCOGENE ALLOWS EGF TO REGULATE NEU TYROSINE KINASE AND CELL-TRANSFORMATION [J].
LEHVASLAIHO, H ;
LEHTOLA, L ;
SISTONEN, L ;
ALITALO, K .
EMBO JOURNAL, 1989, 8 (01) :159-166